These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2487514)

  • 21. Biochemical and cytological features of diffuse mesotheliomas of the pleura.
    Matzel W
    Arch Geschwulstforsch; 1985; 55(4):259-64. PubMed ID: 4037997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic approach of effusion cytology using computerized image analysis.
    Athanassiadou P; Kavantzas N; Davaris P; Gonidi M; Liossi A; Nakopoulou L; Petrakakou E; Athanassiades P
    J Exp Clin Cancer Res; 2002 Mar; 21(1):49-56. PubMed ID: 12071529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
    Marchevsky AM; Gil J; Caccamo D
    Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
    Weyn B; Van De Wouwer G; Koprowski M; Van Daele A; Dhaene K; Scheunders P; Jacob W; Van Marck E
    J Pathol; 1999 Dec; 189(4):581-9. PubMed ID: 10629562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleural sarcomatoid malignant mesothelioma consisting of histiocytoid cells.
    Kawahara K; Nagano T; Matsui K; Kawai T; Iwasaki T
    Pathol Int; 2007 Apr; 57(4):229-31. PubMed ID: 17316420
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytodiagnosis of pleural mesotheliomas].
    Castelain G; Castelain C; Pretet S; Kreis B
    Presse Med (1893); 1969 Feb; 77(6):197-9. PubMed ID: 4182143
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma.
    Shin HJ; Shin DM; Tarco E; Sneige N
    Cancer; 2003 Aug; 99(4):233-9. PubMed ID: 12925985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flow cytometry and malignant pleural mesotheliomas. Value in the histologic and cytologic diagnosis].
    Courtin P; Foulet A; Sartiaux C; Gosselin B
    Arch Anat Cytol Pathol; 1993; 41(5-6):229-31. PubMed ID: 8135584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumour).
    Mukherjee TM; Swift JG; Henderson DW
    J Submicrosc Cytol Pathol; 1988 Jan; 20(1):195-208. PubMed ID: 3370618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An image analysis workstation for the pathology laboratory.
    Erler BS; Chein K; Marchevsky AM
    Mod Pathol; 1993 Sep; 6(5):612-8. PubMed ID: 8248118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign and malignant pleural mesothelioma.
    Antman KH; Corson JM
    Clin Chest Med; 1985 Mar; 6(1):127-40. PubMed ID: 3891207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant mesothelioma with osteoblastic heterologous elements].
    Chalabreysse L; Guillaud C; Tabib A; Loire R; Thivolet-Béjui F
    Ann Pathol; 2001 Oct; 21(5):428-30. PubMed ID: 11852361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The malignancy grading method is not a reliable assessment of malignancy in mesothelioma.
    Tierney G; Wilkinson MJ; Jones JS
    J Pathol; 1990 Mar; 160(3):209-11. PubMed ID: 2335801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exudate characteristics in pleural mesotheliomas].
    Zhuravlev AV
    Vrach Delo; 1982 Nov; (11):62-5. PubMed ID: 7157763
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinicopathological study of 23 pleural malignant mesotheliomas].
    Bombí JA; Xaubet A; Letang E; Ribalta T; Picado C; Agustí Vidal A; Sánchez-Lloret J; Cardesa A
    Rev Clin Esp; 1988 May; 182(9):464-70. PubMed ID: 3175139
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic contribution of the determination of CEA, pH, glucose and lactase dehydrogenase in the pleural fluid in patients with mesothelioma].
    Rapellino M; Borasio P; Baldi S; Coni F; Oliaro A; Libertucci D; Ardissone F
    Minerva Med; 1987 Mar; 78(5):317-9. PubMed ID: 3822223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and reproducibility of pleural effusion cytology.
    Fassina A; Fedeli U; Corradin M; Da Frè M; Fabbris L
    Leg Med (Tokyo); 2008 Jan; 10(1):20-5. PubMed ID: 17702624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image analysis of mesothelioma. II. Discrimination of mesothelioma from metastatic serous ovarian adenocarcinoma.
    Protopapa E; Delides G; Miaoulis G; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 2000 Aug; 22(4):338-45. PubMed ID: 10965411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.